NASDAQ
Immix Biopharma, Inc. (IMMX) has a fcf yield of -14.30% as of Friday, May 29, 2026. This represents a 18.63% increase compared to its 12-month average of -17.58%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.